The circ-ERBB2 functions as an oncogene in GC and might be useful in developing promising therapies for this fatal malignancy.
Upregulation of circular RNA circ-ERBB2 predicts unfavorable prognosis and facilitates the progression of gastric cancer via miR-503/CACUL1 and miR-637/MMP-19 signaling.